VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $214,000 | -99.5% | 9,200 | -99.5% | 0.00% | -100.0% |
Q3 2016 | $42,248,000 | +41.7% | 1,722,415 | +16.1% | 0.01% | +33.3% |
Q2 2016 | $29,818,000 | -47.3% | 1,483,154 | -31.0% | 0.01% | -50.0% |
Q1 2016 | $56,530,000 | -97.5% | 2,148,801 | -90.2% | 0.01% | -97.4% |
Q4 2015 | $2,220,949,000 | -37.9% | 21,853,814 | +9.0% | 0.47% | -41.3% |
Q3 2015 | $3,575,389,000 | -21.3% | 20,046,911 | -2.0% | 0.80% | -14.9% |
Q2 2015 | $4,545,817,000 | +13.7% | 20,463,632 | +1.7% | 0.94% | +13.3% |
Q1 2015 | $3,996,423,000 | +56.5% | 20,125,336 | +12.8% | 0.82% | +52.2% |
Q4 2014 | $2,553,779,000 | +11.2% | 17,842,284 | +2.0% | 0.54% | +8.2% |
Q3 2014 | $2,295,728,000 | +10.6% | 17,497,210 | +6.3% | 0.50% | +11.6% |
Q2 2014 | $2,075,927,000 | +12.0% | 16,455,707 | +17.1% | 0.45% | +7.9% |
Q1 2014 | $1,853,049,000 | -46.6% | 14,056,827 | -52.5% | 0.42% | +4.5% |
Q4 2013 | $3,470,964,000 | +114.6% | 29,567,206 | +90.7% | 0.40% | -1.5% |
Q3 2013 | $1,617,735,000 | -39.3% | 15,504,335 | -50.0% | 0.40% | +13.2% |
Q2 2013 | $2,666,712,000 | – | 30,982,540 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |